Filed Under: Policy Theater
Washington announced a move. Headlines exploded. Cable news rushed alerts. Cannabis was suddenly “rescheduled,” according to the narrative. The sound was historic. The substance was not.
The White House issued executive direction and public signaling, urging federal agencies to continue the rescheduling process
What it does is restart a process that has already been stalled for years.
In August 2023, the U.S. Department of Health and Human Services and the Food and Drug Administration completed a scientific review. They formally recommended moving cannabis to Schedule III, concluding that it has accepted medical use and a lower abuse potential than Schedule I and II substances. That recommendation was sent to the Department of Justice, which proposed a rule change in 2024 and opened a public comment period.
By late 2024, the Drug Enforcement Administration appointed Judge John Mulrooney (DEA Administrative Law Judge) to oversee rescheduling hearings and named 25 witnesses, including several individuals who had previously opposed rescheduling. Legal challenges followed. The hearings were delayed and effectively stalled
None of that changed today.
The executive order does not bypass rulemaking. It does not force the DEA to act. It does not deschedule cannabis. It does not reconcile federal prohibition with state legal markets serving more than half of the U.S. population. It applies pressure without delivering results.
The Marijuana Policy Project made that clear.
HELP POT CULTURE MAGAZINE STAY ALIVE, AND INDEPENDENT
MPP Executive Director Adam J. Smith said,
“While we welcome the proposal to move cannabis from Schedule I to Schedule III, neither the plant itself nor its naturally occurring component cannabinoids belong on the schedule at all,”
Smith did not soften the rest.
“A move to Schedule III does nothing to end hundreds of thousands of possession arrests each year, nor does it fix the ongoing disconnect between federal prohibition and the regulated state markets under which more than half of American adults live.”
Those are the facts missing from most coverage.
Advertisement
F O R T H E C U L T U R E B Y T H E C U L T U R E
WHEN THE UN CAN’T STOP LEGAL WEED
As cannabis reform accelerates worldwide, the UN’s International Narcotics Control Board continues warning that decades old drug treaties still apply. This feature examines the INCB’s actual authority, the limits of treaty enforcement, and why global legalization is advancing despite institutional resistance rooted in prohibition era frameworks.
The Federal Hemp Blueprint That Isn’t
A proposed federal hemp framework is being sold as long overdue clarity for a chaotic market. But beneath the promise of order, the structure reveals rigid caps, unresolved enforcement questions, and a quiet shift of power away from states and smaller producers. We break down what the proposal does, what it avoids, and why the…
Advertisement
Schedule III would matter if finalized. It could expand medical research. It could ease prescribing barriers. It could remove Section 280E tax penalties that punish state-legal cannabis businesses. Those are structural changes, not symbolic ones.
But Schedule III would still leave cannabis illegal at the federal level. Criminal penalties would remain. DEA authority would remain. The contradiction would remain.
This is why advocacy groups have warned against mistaking rescheduling for reform. Rescheduling is not legalization. It is not justice. It is not freedom.
NORML has said this for years. Regulation must reflect science, not fear. Moving cannabis between schedules without removing it from the Controlled Substances Act simply reshuffles prohibition.
Calling this moment historic ignores the timeline. The science was settled more than a year ago. The rulemaking already exists. The hearings are frozen. An executive order does not resolve any of that.
It signals intent, not outcome.
Cannabis users have seen this cycle before. Announcements. Promises. Press releases. Then delays, stalls, and silence. The system survives by substituting motion for progress.
The only reason this moment exists at all is public pressure. Patients. Advocates. Industry workers. Voters. Pressure forced the system to blink.
But blinking is not surrender.
Until cannabis is fully descheduled and prohibition is dismantled, every move like this remains partial, conditional, and fragile. The Schedule III scam is not about what was done. It is about what was not.
Rescheduling is not reform.
©2025 Pot Culture Magazine. All rights reserved. This content is the exclusive property of Pot Culture Magazine and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission from the publisher, except for brief quotations in critical reviews.
F O R T H E C U L T U R E B Y T H E C U L T U R E
Reefer Report Card Vol. 31: The Retreat Becomes Routine
Reefer Report Card Vol. 31 examines a week where cannabis reform quietly retreated. Ballot rollbacks gained traction, federal action stalled, and patients remained unprotected. Legal weed stayed popular, but oversight weakened and accountability slipped. Another week where legalization survived while governance failed
David Krumholtz and the Collapse of Nuance
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
Reefer Report Card Vol. 30: The Floor Starts to Give
Reefer Report Card Vol. 30 tracks a week where legalization stalled while rollback efforts gained ground. Ballot initiatives threatened regulated markets, federal reform stayed stalled, and patients were left navigating uncertainty. Demand remained strong, but oversight weakened. Another week where cannabis survived while governance quietly failed.
Discover more from POT CULTURE MAGAZINE
Subscribe to get the latest posts sent to your email.
Leave a comment